Literature DB >> 33397478

Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.

Rabia Hussain1,2, Mohamed Azmi Hassali3, Furqan Hashmi4, Tayyaba Akram5.   

Abstract

BACKGROUND: Spontaneous reporting of adverse drug reactions (ADRs) is a method of monitoring the safety of drugs and is the basic strategy for the post-marketing surveillance of the suspected drugs. Despite its importance, there is very little reporting of ADRs by healthcare professionals. The present study has evaluated the knowledge, attitude and practices of health care professionals (HCPs) regarding pharmacovigilance activities in Lahore, Pakistan.
METHODS: A cross-sectional questionnaire-based survey was employed, and a convenience sampling was opted to collect the data among physicians, pharmacists and nurses working in tertiary care public hospitals of Lahore, Pakistan from September 2018 to January 2019.
RESULTS: Of the 384 questionnaires distributed, 346 health care professionals responded to the questionnaire (90.10% response rate). Most participants had good knowledge about ADR reporting, but pharmacist had comparatively better knowledge than other HCPs regarding ADR (89.18%) pharmacovigilance system (81.08%), its centres (72.97%) and function (91.89%). Most of the participants exhibited positive attitude regarding ADR reporting, such as 49.1% of physicians (P < 0.05), 70.2% pharmacists and 76.1% nurses showed a positive attitude that they are the most important HCPs to report an ADR. About 64.3% of physicians (P < 0.05) emphasized that consulting other colleagues is important before reporting an ADR. Of all, 77.7% physicians, 75.7% pharmacists and 68% of nurses had positive attitude that ADR reporting is a professional obligation and 67.6% of the pharmacists stated that they have reported ADRs in their workplace and 77.2% nurses have verbally reported ADRs to the concerned personnel or department.
CONCLUSION: Among all HCPs, pharmacists had better knowledge about ADR reporting and pharmacovigilance. All HCPs had positive attitude and inclination towards ADR reporting. The discrepancies were observed in the practices related to ADR reporting, whereas most of the participants including physicians and nurses did not report any ADR. Based on the above, strategies are needed to educate, train, and empower the HCPs in the domain of pharmacovigilance.

Entities:  

Keywords:  Adverse drug reaction; Adverse drug reaction reporting; Drug regulatory authority of Pakistan; Healthcare professionals; Medicines safety; Pharmacovigilance

Year:  2021        PMID: 33397478     DOI: 10.1186/s40545-020-00287-3

Source DB:  PubMed          Journal:  J Pharm Policy Pract        ISSN: 2052-3211


  36 in total

1.  Pharmacists' role in reporting adverse drug reactions in an international perspective.

Authors:  Kees van Grootheest; Sten Olsson; Mary Couper; Lolkje de Jong-van den Berg
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-07       Impact factor: 2.890

2.  Pharmacovigilance in the Middle East: a survey of 13 arabic-speaking countries.

Authors:  Kerry Wilbur
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

Review 3.  Strategies to improve adverse drug reaction reporting: a critical and systematic review.

Authors:  Cristian Gonzalez-Gonzalez; Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

Review 4.  Randomized controlled trials covering pharmaceutical care and medicines management: A systematic review of literature.

Authors:  Zaheer-Ud-Din Babar; Rozina Kousar; Ghulam Murtaza; Saira Azhar; Shujaat Ali Khan; Louise Curley
Journal:  Res Social Adm Pharm       Date:  2017-06-19

Review 5.  Factors affecting patient reporting of adverse drug reactions: a systematic review.

Authors:  Rania Al Dweik; Dawn Stacey; Dafna Kohen; Sanni Yaya
Journal:  Br J Clin Pharmacol       Date:  2016-11-25       Impact factor: 4.335

6.  Spontaneous adverse drug reaction reporting vs event monitoring: a comparison.

Authors:  A P Fletcher
Journal:  J R Soc Med       Date:  1991-06       Impact factor: 18.000

Review 7.  Epidemiology of adverse drug reactions in Europe: a review of recent observational studies.

Authors:  Jacoline C Bouvy; Marie L De Bruin; Marc A Koopmanschap
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.606

8.  Adverse drug reaction reporting in New Zealand: implications for pharmacists.

Authors:  Monica Zolezzi; Nirasha Parsotam
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

9.  Identifying priority medicines policy issues for New Zealand: a general inductive study.

Authors:  Zaheer-Ud-Din Babar; Susan Francis
Journal:  BMJ Open       Date:  2014-05-28       Impact factor: 2.692

10.  A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan.

Authors:  Rabia Hussain; Mohamed Azmi Hassali; Furqan Hashmi; Maryam Farooqui
Journal:  J Pharm Policy Pract       Date:  2018-07-19
View more
  3 in total

1.  Assessment of the Current State of Pharmacovigilance System in Pakistan Using Indicator-Based Assessment Tool.

Authors:  Muhammad Akhtar Abbas Khan; Saima Hamid; Tofeeq Ur-Rehman; Zaheer-Ud-Din Babar
Journal:  Front Pharmacol       Date:  2022-01-14       Impact factor: 5.810

2.  Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey.

Authors:  Rabia Hussain; Tayyaba Akram; Mohamed Azmi Hassali; Jaya Muneswarao; Anees Ur Rehman; Furqan Hashmi; Zaheer-Ud-Din Babar
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

3.  Knowledge, attitude and practice of hospital pharmacists towards pharmacovigilance and adverse drug reaction reporting in Najran, Saudi Arabia.

Authors:  Ali Mohamed Alshabi; Mohammed Ashique K Shaikh; Ibrahim Ahmed Shaikh; Saad Ahmed Alkahtani; Adel Aljadaan
Journal:  Saudi Pharm J       Date:  2022-04-30       Impact factor: 4.562

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.